AVITA Medical SG&A Expense (Quarterly) Insights

AVITA Medical Inc (RCEL)

9.23 +0.32 (+3.53%) USD | NASDAQ | May 07, 11:49

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	17.97M
September 30, 2023	16.66M
June 30, 2023	16.17M
March 31, 2023	14.84M
December 31, 2022	11.66M
September 30, 2022	10.42M
June 30, 2022	10.80M
March 31, 2022	12.36M
September 30, 2021	8.867M

Date	Value
June 30, 2021	9.421M
March 31, 2021	9.071M
December 31, 2020	7.001M
September 30, 2020	11.57M
June 30, 2020	13.97M
March 31, 2020	17.16M
December 31, 2019	11.08M
September 30, 2019	6.705M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

6.705M

Minimum

Sep 2019

17.97M

Maximum

Dec 2023

12.10M

Average

11.57M

Median

Sep 2020

SG&A Expense (Quarterly) Benchmarks